After years of hits and misses trying to unlock the mysteries of Alzheimer’s disease, experts say recent research has yielded ...

It’s 2017 and I’m working as a barrister on a very challenging case in Liverpool: a four-handed, cut-throat murder case in ...

Natalie Bryan's dad was diagnosed with Alzheimer's in 2024. She thought it would change everything, but he hasn't declined at ...

The co-author of the study told Newsweek the drug could help slow Alzheimer's progression and preserve independence for ...

A drug originally developed for spinal cord injury may offer a fresh approach to treating Alzheimer’s disease. In mouse ...

The world's largest dementia research conference showcased the global collaboration driving advances in diagnosis, treatment ...

The FDA has approved a subcutaneous dose for initiation of lecanemab treatment in adults with Alzheimer’s disease, according ...

Putnam County Circuit Judge Mark Sorsaia is resigning effective at the end of the month after being diagnosed with early ...

In a new study, elevated blood biomarkers of Alzheimer's in healthy adults were tied to future cognitive risk. But the test ...

Scientists are now targeting early Alzheimer's warning signs, not just protein plaques. An experimental drug, KCL-286, ...

Families caring for someone with advanced Alzheimer’s disease face a daily struggle with agitation, a symptom that can ...

New genetically targeted therapies promise to revolutionize treatment for heart disease, Alzheimer's and rare conditions—but ...